MAPK3 and Polyuria: Since pretreatment with the MAPK inhibitor abolished Li+-induced upregulation of pSer261-AQP2, ERK1,2 and p38, they have been suggested as early targets of Li+, possibly playing a role in the onset of Li+-induced polyuria [75].